Design of Tracers in Fluorescence Polarization Assay for Extensive Application in Small Molecule Drug Discovery.
暂无分享,去创建一个
Lei Wang | Qiuyue Zhang | Liwen Hua | Jinying Gu | Qidong You | Danni Wang | Keran Wang | Yuxuan Wang
[1] Wei Wang,et al. Discovery of 2H-Indazole-3-carboxamide Derivatives as Novel Potent Prostanoid EP4 Receptor Antagonists for Colorectal Cancer Immunotherapy. , 2023, Journal of medicinal chemistry.
[2] R. Hoffmann,et al. A High-Throughput Fluorescence Polarization-Based Assay for the SH2 Domain of STAT4 , 2022, Methods and protocols.
[3] O. Rossanese,et al. Discovering cell-active BCL6 inhibitors: effectively combining biochemical HTS with multiple biophysical techniques, X-ray crystallography and cell-based assays , 2022, Scientific Reports.
[4] Helder Veras Ribeiro Filho,et al. Discovery and structural characterization of chicoric acid as a SARS-CoV-2 nucleocapsid protein ligand and RNA binding disruptor , 2022, Scientific Reports.
[5] G. Besra,et al. Quantitative affinity measurement of small molecule ligand binding to major histocompatibility complex class-I–related protein 1 MR1 , 2022, The Journal of biological chemistry.
[6] C. Fierke,et al. Gambogic acid and juglone inhibit RNase P through distinct mechanisms , 2022, The Journal of biological chemistry.
[7] G. Popowicz,et al. Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery. , 2022, Journal of medicinal chemistry.
[8] C. Schofield,et al. In Situ Inhibitor Synthesis and Screening by Fluorescence Polarization: An Efficient Approach for Accelerating Drug Discovery , 2022, Angewandte Chemie.
[9] Yajun Zhang,et al. Small-Molecule PROTACs for Cancer Immunotherapy , 2022, Molecules.
[10] Shaoyong Lu,et al. Rational design of a sensitivity-enhanced tracer for discovering efficient APC–Asef inhibitors , 2022, Nature Communications.
[11] S. Chi,et al. Application of nanopore sensors for biomolecular interactions and drug discovery. , 2022, Chemistry, an Asian journal.
[12] J. Bushweller,et al. Small-Molecule Inhibitors of the MLL1 CXXC Domain, an Epigenetic Reader of DNA Methylation. , 2022, ACS medicinal chemistry letters.
[13] Yan Fan,et al. Discovery of a potent, selective and cell active inhibitor of m6A demethylase ALKBH5. , 2022, European journal of medicinal chemistry.
[14] M. Tian,et al. Application of per-Residue Energy Decomposition to Design Peptide Inhibitors of PSD95 GK Domain , 2022, Frontiers in Molecular Biosciences.
[15] Lei Wang,et al. Methods for the Discovery and Identification of Small Molecules Targeting Oxidative Stress-Related Protein–Protein Interactions: An Update , 2022, Antioxidants.
[16] K. Lepikhov,et al. First Small-Molecule Inhibitors Targeting the RNA-Binding Protein IGF2BP2/IMP2 for Cancer Therapy. , 2022, ACS chemical biology.
[17] Minyong Li,et al. Discovery of small-molecule fluorescent probes for C-Met. , 2022, European journal of medicinal chemistry.
[18] M. Pazgier,et al. Design of ultrahigh-affinity and dual-specificity peptide antagonists of MDM2 and MDMX for P53 activation and tumor suppression , 2021, Acta pharmaceutica Sinica. B.
[19] L. Zhong,et al. Small molecules in targeted cancer therapy: advances, challenges, and future perspectives , 2021, Signal Transduction and Targeted Therapy.
[20] Ina Rothenaigner,et al. Brief Guide: Experimental Strategies for High-Quality Hit Selection from Small-Molecule Screening Campaigns , 2021, SLAS discovery : advancing life sciences R & D.
[21] I. Pavlinov,et al. Development of a High-Throughput, Compound-Multiplexed Fluorescence Polarization Assay to Identify ATG5–ATG16L1 Protein–Protein Interaction Inhibitors , 2021, SLAS discovery : advancing life sciences R & D.
[22] Peng Wu,et al. Trisubstituted Pyrrolinones as Small-Molecule Inhibitors Disrupting the Protein–RNA Interaction of LIN28 and Let-7 , 2021, ACS medicinal chemistry letters.
[23] R. Bauer,et al. Natural products in drug discovery: advances and opportunities , 2021, Nature Reviews Drug Discovery.
[24] Taosheng Chen,et al. Development of BODIPY FL VH032 as a High-Affinity and Selective von Hippel–Lindau E3 Ligase Fluorescent Probe and Its Application in a Time-Resolved Fluorescence Resonance Energy-Transfer Assay , 2020, ACS omega.
[25] Lei Chang,et al. Neuroprotective Effect of N-Cyclohexylethyl-[A/G]-[D/E]-X-V Peptides on Ischemic Stroke by Blocking nNOS-CAPON Interaction. , 2020, ACS chemical neuroscience.
[26] Mingjie Zhang,et al. Identification of Novel Fragments Binding to the PDZ1‐2 Domain of PSD‐95 , 2020, ChemMedChem.
[27] M. Baud,et al. Current strategies for the design of PROTAC linkers: a critical review , 2020, Exploration of targeted anti-tumor therapy.
[28] I. Coin,et al. Capturing Peptide–GPCR Interactions and Their Dynamics , 2020, Molecules.
[29] K. Ohno,et al. Binding Assays Using a Benzofurazan-Labeled Fluorescent Probe for Estrogen Receptor-Ligand Interactions. , 2020, Chemical & pharmaceutical bulletin.
[30] T. Strovas,et al. AlphaScreen Identifies MSUT2 Inhibitors for Tauopathy-Targeting Therapeutic Discovery , 2020, SLAS discovery : advancing life sciences R & D.
[31] S. Mattoo,et al. A Fluorescence Polarization-Based High-Throughput Screen to Identify the First Small-Molecule Modulators of the Human Adenylyltransferase HYPE/FICD , 2020, International journal of molecular sciences.
[32] Karunakaran A Kalesh,et al. Detectives and helpers: Natural products as resources for chemical probes and compound libraries. , 2020, Pharmacology & therapeutics.
[33] Ilaria Iacobucci,et al. From classical to new generation approaches: An excursus of -omics methods for investigation of protein-protein interaction networks. , 2020, Journal of proteomics.
[34] J. Zhao,et al. Design, Synthesis and Structure-Activity Relationships of Indoline-Based Kelch-like ECH Associated Protein 1-Nuclear Factor (Erythroid-derived 2)-like 2 (Keap1-Nrf2) Protein-Protein Interaction Inhibitors. , 2020, Journal of medicinal chemistry.
[35] X. Le,et al. Aptamer binding assays and molecular interaction studies using fluorescence anisotropy - A review. , 2020, Analytica chimica acta.
[36] J. Karanicolas,et al. Identification and Validation of an Aspergillus nidulans Secondary Metabolite Derivative as an Inhibitor of the Musashi-RNA Interaction , 2020, Cancers.
[37] G. Rudenko,et al. Discovery of phenanthridine analogues as novel chemical probes disrupting the binding of DNA to ΔFosB homodimers and ΔFosB/JunD heterodimers. , 2020, Bioorganic & medicinal chemistry letters.
[38] Qingxin Li,et al. Mechanisms of Action for Small Molecules Revealed by Structural Biology in Drug Discovery , 2020, International journal of molecular sciences.
[39] Peng Wu. Inhibition of RNA-binding proteins with small molecules , 2020, Nature Reviews Chemistry.
[40] J. Wade,et al. Traceable Peptidic Ligands that Target Ghrelin Receptors. , 2020, Current protein & peptide science.
[41] P. Njogu,et al. Exploring different approaches to improve the success of drug discovery and development projects: a review , 2020, Future Journal of Pharmaceutical Sciences.
[42] Yong Chen,et al. Development and Optimization of a Cascade of Screening Assays for Inhibitors of TRF2. , 2020, Analytical biochemistry.
[43] L. Dekker,et al. Use of BODIPY-Labeled ATP Analogues in the Development and Validation of a Fluorescence Polarization-Based Assay for Screening of Kinase Inhibitors , 2020, ACS omega.
[44] E. Breukink,et al. Fluorescence anisotropy assays for high throughput screening of compounds binding to lipid II, PBP1b, FtsW and MurJ , 2020, Scientific Reports.
[45] Rong Huang,et al. Development of fluorescence polarization-based competition assay for nicotinamide N-methyltransferase , 2020, bioRxiv.
[46] I. Wilson,et al. An influenza A hemagglutinin small-molecule fusion inhibitor identified by a new high-throughput fluorescence polarization screen , 2020, Proceedings of the National Academy of Sciences.
[47] Junjie Zhu,et al. Structure‐based design, synthesis, and evaluation of Bcl‐2/Mcl‐1 dual inhibitors , 2020, Archiv der Pharmazie.
[48] Dean G. Brown,et al. Opportunities and challenges in phenotypic screening for neurodegenerative disease research. , 2020, Journal of medicinal chemistry.
[49] D. Watt,et al. Discovery and development of small-molecule inhibitors of glycogen synthase. , 2020, Journal of medicinal chemistry.
[50] R. Judson,et al. High-Throughput Screening to Predict Chemical-Assay Interference , 2020, Scientific Reports.
[51] Ruixiang Li,et al. Discovery of the anti-angiogenesis effect of eltrombopag in breast cancer through targeting of HuR protein , 2020, Acta pharmaceutica Sinica. B.
[52] Maria Paola Costi,et al. Designing Chimeric Molecules for Drug Discovery by Leveraging Chemical Biology , 2020, Journal of medicinal chemistry.
[53] Emma J. Chory,et al. A Deep Learning Approach to Antibiotic Discovery , 2020, Cell.
[54] S. Djordjević,et al. Discovery of a novel fluorescent chemical probe suitable for evaluation of neuropilin‐1 binding of small molecules , 2020, Drug development research.
[55] C. Domene,et al. Mechanism of molecular oxygen diffusion in a hypoxia sensing prolyl hydroxylase using multiscale simulation. , 2020, Journal of the American Chemical Society.
[56] M. Sattler,et al. Developing Inhibitors of the p47phox-p22phox Protein-Protein Interaction by Fragment-Based Drug Discovery. , 2020, Journal of Medicinal Chemistry.
[57] Anna K H Hirsch,et al. Concepts and Core Principles of Fragment-Based Drug Design , 2019, Molecules.
[58] E. Ortlund,et al. Development of a Versatile and Sensitive Direct Ligand Binding Assay for Human NR5A Nuclear Receptors. , 2019, ACS medicinal chemistry letters.
[59] P. Ratcliffe,et al. Structure‐Activity Relationship and Crystallographic Studies on 4‐Hydroxypyrimidine HIF Prolyl Hydroxylase Domain Inhibitors , 2019, ChemMedChem.
[60] T. Schulz,et al. Fragment-Based Discovery of a Qualified Hit Targeting the Latency-Associated Nuclear Antigen of the Oncogenic Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8. , 2019, Journal of medicinal chemistry.
[61] Wolfgang Jahnke,et al. Fragment-Based Drug Discovery: Advancing Fragments in the Absence of Crystal Structures. , 2019, Cell chemical biology.
[62] Xing Chen,et al. MicroRNA-small molecule association identification: from experimental results to computational models , 2018, Briefings Bioinform..
[63] Pia Hansson,et al. A Comparative Study of Fluorescence Assays in Screening for BRD4. , 2018, Assay and drug development technologies.
[64] Jing Gu,et al. Click Chemistry-Based Discovery of [3-Hydroxy-5-(1 H-1,2,3-triazol-4-yl)picolinoyl]glycines as Orally Active Hypoxia-Inducing Factor Prolyl Hydroxylase Inhibitors with Favorable Safety Profiles for the Treatment of Anemia. , 2018, Journal of medicinal chemistry.
[65] Arielle Rowe,et al. Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery , 2018, International journal of molecular sciences.
[66] Mukul R Jain,et al. Prolyl Hydroxylase Inhibitors: A Breakthrough in the Therapy of Anemia Associated with Chronic Diseases. , 2018, Journal of medicinal chemistry.
[67] H. Dudek,et al. Inhibition of Glycogen Synthase II with RNAi Prevents Liver Injury in Mouse Models of Glycogen Storage Diseases , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.
[68] Matthias W. Hentze,et al. A brave new world of RNA-binding proteins , 2018, Nature Reviews Molecular Cell Biology.
[69] Shaoyong Lu,et al. Peptidomimetic inhibitors of APC-Asef interaction block colorectal cancer migration. , 2017, Nature chemical biology.
[70] L. Lavis. Teaching Old Dyes New Tricks: Biological Probes Built from Fluoresceins and Rhodamines. , 2017, Annual review of biochemistry.
[71] Lee A. D. Cooper,et al. The OncoPPi network of cancer-focused protein–protein interactions to inform biological insights and therapeutic strategies , 2017, Nature Communications.
[72] Anthony D. Keefe,et al. DNA-encoded chemistry: enabling the deeper sampling of chemical space , 2016, Nature Reviews Drug Discovery.
[73] Ajit Jadhav,et al. Fluorescence polarization assays in high-throughput screening and drug discovery: a review , 2016, Methods and applications in fluorescence.
[74] Q. You,et al. Affinity-Based Fluorescence Polarization Assay for High-Throughput Screening of Prolyl Hydroxylase 2 Inhibitors. , 2015, ACS medicinal chemistry letters.
[75] J. Chambers,et al. Modular chemical probes for visualizing and tracking endogenous ion channels , 2015, Neuropharmacology.
[76] J. Konvalinka,et al. Design of highly potent urea-based, exosite-binding inhibitors selective for glutamate carboxypeptidase II. , 2015, Journal of medicinal chemistry.
[77] E. Nishida,et al. Dual role of YAP and TAZ in renewal of the intestinal epithelium , 2014, Nature Cell Biology.
[78] Lu Lu,et al. Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor , 2014, Nature Communications.
[79] Christopher J. Contreras,et al. Structural basis for 2′-phosphate incorporation into glycogen by glycogen synthase , 2013, Proceedings of the National Academy of Sciences.
[80] Shinya Oishi,et al. Affinity-based screening of MDM2/MDMX-p53 interaction inhibitors by chemical array: identification of novel peptidic inhibitors. , 2013, Bioorganic & medicinal chemistry letters.
[81] Alexander D. MacKerell,et al. The novel BH3 α-helix mimetic JY-1-106 induces apoptosis in a subset of cancer cells (lung cancer, colon cancer and mesothelioma) by disrupting Bcl-xL and Mcl-1 protein–protein interactions with Bak , 2013, Molecular Cancer.
[82] L. Lam,et al. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets , 2013, Nature Medicine.
[83] M. Hall,et al. HIF-independent role of prolyl hydroxylases in the cellular response to amino acids , 2012, Oncogene.
[84] A. Kong,et al. Optimization of Fluorescently Labeled Nrf2 Peptide Probes and the Development of a Fluorescence Polarization Assay for the Discovery of Inhibitors of Keap1-Nrf2 Interaction , 2012, Journal of biomolecular screening.
[85] R. DuBois,et al. Identification of influenza endonuclease inhibitors using a novel fluorescence polarization assay. , 2012, ACS chemical biology.
[86] R. Verhaak,et al. Transformation by the R Enantiomer of 2-Hydroxyglutarate Linked to EglN Activation , 2012, Nature.
[87] Geng Wu,et al. Structural basis for the recognition of Asef by adenomatous polyposis coli , 2011, Cell Research.
[88] Anton Simeonov,et al. Fluorescence polarization assays in small molecule screening , 2011, Expert opinion on drug discovery.
[89] Thomas D. Pollard,et al. A Guide to Simple and Informative Binding Assays , 2010, Molecular biology of the cell.
[90] Stéphanie Pérot,et al. Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery. , 2010, Drug discovery today.
[91] Erin E. Carlson,et al. Natural products as chemical probes. , 2010, ACS chemical biology.
[92] M. Wendt. Discovery of ABT-263, a Bcl-family protein inhibitor: observations on targeting a large protein–protein interaction , 2008, Expert opinion on drug discovery.
[93] Brian J Eastwood,et al. A Comparison of Assay Performance Measures in Screening Assays: Signal Window, Z' Factor, and Assay Variability Ratio , 2006, Journal of biomolecular screening.
[94] Rainer Bischoff,et al. Receptor-ligand binding assays: technologies and applications. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[95] M. Blank,et al. Aptamers as tools for target validation. , 2005, Current opinion in chemical biology.
[96] Hans Clevers,et al. Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells , 2005, Nature.
[97] S. Eremin,et al. Fluorescence polarization immunoassay based on a monoclonal antibody for the detection of ochratoxin A , 2004 .
[98] Xueliang Fang,et al. Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization. , 2004, Analytical biochemistry.
[99] G. Wagner,et al. Selective inhibition of calcineurin-NFAT signaling by blocking protein-protein interaction with small organic molecules. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[100] Ann C Horan,et al. Use of Red-Shifted Dyes in a Fluorescence Polarization AKT Kinase Assay for Detection of Biological Activity in Natural Product Extracts , 2004, Journal of biomolecular screening.
[101] S. Cope,et al. Diagnosis of militarily relevant diseases using oral fluid and saliva antibodies: fluorescence polarization immunoassay. , 2003, Military medicine.
[102] David K. Johnson. Fluorescence polarization immunoassays for metal ions. , 2003, Combinatorial chemistry & high throughput screening.
[103] K. Ervin,et al. Development and application of fluorescence polarization assays in drug discovery. , 2003, Combinatorial chemistry & high throughput screening.
[104] S. Eremin,et al. Fluorescence polarization immunoassays for pesticides. , 2003, Combinatorial chemistry & high throughput screening.
[105] D. Earnshaw,et al. Real Experiences of uHTS: A Prototypic 1536-Well Fluorescence Anisotropy-Based uHTS Screen and Application of Well-Level Quality Control Procedures , 2001, Journal of biomolecular screening.
[106] J. Owicki,et al. Fluorescence Polarization and Anisotropy in High Throughput Screening: Perspectives and Primer , 2000, Journal of biomolecular screening.
[107] D. Jameson,et al. Quantification of protein-protein interactions using fluorescence polarization. , 1999, Methods.
[108] A. Saltiel,et al. The Role of Glucose Metabolites in the Activation and Translocation of Glycogen Synthase by Insulin in 3T3-L1 Adipocytes* , 1999, The Journal of Biological Chemistry.
[109] Y. Barenholz,et al. Characterization of liposomes and other lipid assemblies by multiprobe fluorescence polarization. , 1993, Chemistry and physics of lipids.
[110] E. Fry,et al. Polarized Light Scattering by Small Particles , 1982 .
[111] G. Omenn,et al. Studies of polypeptide structure by fluorescence techniques. III. Interaction between dye and macromolecule in fluorescent conjugates , 1967, Biopolymers.
[112] G. Weber. Polarization of the fluorescence of macromolecules. I. Theory and experimental method. , 1952, The Biochemical journal.
[113] D. Laurence,et al. A study of the adsorption of dyes on bovine serum albumin by the method of polarization of fluorescence. , 1952, The Biochemical journal.
[114] OUP accepted manuscript , 2021, Nucleic Acids Research.
[115] W. Sippl,et al. A fluorescence anisotropy-based Myt1 kinase binding assay. , 2014, Assay and drug development technologies.
[116] Xinyi Huang,et al. Fluorescence polarization competition assay: the range of resolvable inhibitor potency is limited by the affinity of the fluorescent ligand. , 2003, Journal of biomolecular screening.